SG11201912036XA - A peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response - Google Patents

A peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response

Info

Publication number
SG11201912036XA
SG11201912036XA SG11201912036XA SG11201912036XA SG11201912036XA SG 11201912036X A SG11201912036X A SG 11201912036XA SG 11201912036X A SG11201912036X A SG 11201912036XA SG 11201912036X A SG11201912036X A SG 11201912036XA SG 11201912036X A SG11201912036X A SG 11201912036XA
Authority
SG
Singapore
Prior art keywords
analgesia
peripherally
inflammatory response
opioid agonist
pain states
Prior art date
Application number
SG11201912036XA
Inventor
Craig Hartrick
Original Assignee
Caventure Drug Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caventure Drug Discovery Inc filed Critical Caventure Drug Discovery Inc
Publication of SG11201912036XA publication Critical patent/SG11201912036XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41881,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
SG11201912036XA 2017-07-06 2018-06-22 A peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response SG11201912036XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762529285P 2017-07-06 2017-07-06
PCT/US2018/038936 WO2019010014A1 (en) 2017-07-06 2018-06-22 A peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response

Publications (1)

Publication Number Publication Date
SG11201912036XA true SG11201912036XA (en) 2020-01-30

Family

ID=64950308

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201912036XA SG11201912036XA (en) 2017-07-06 2018-06-22 A peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response

Country Status (10)

Country Link
US (2) US11185551B2 (en)
EP (1) EP3649132B1 (en)
JP (1) JP7233741B2 (en)
KR (1) KR20200026962A (en)
CN (2) CN116440140A (en)
AU (1) AU2018297214B2 (en)
CA (1) CA3067398A1 (en)
IL (1) IL271772A (en)
SG (1) SG11201912036XA (en)
WO (1) WO2019010014A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3222543A1 (en) * 2021-06-07 2022-12-15 Uwm Research Foundation, Inc. Use of substituted 5-(4-methyl-6-phenyl-4h-benzo[f]imidazo[1,5-a][1,4] diazepin-3-yl)-1,2,4-oxadiazoles in the treatment of inflammatory conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9703988A (en) * 1994-12-12 1998-02-28 Omeros Med Sys Inc Irrigation solution and method for inhibition of pain, inflammation and spasm.
US20030008807A1 (en) * 2001-06-14 2003-01-09 The Regents Of The University Of California Novel signaling pathway for the production of inflammatory pain and neuropathy
US20050152905A1 (en) * 2002-08-22 2005-07-14 Omoigui Osemwota S. Method of biochemical treatment of persistent pain
WO2015114660A1 (en) 2014-01-24 2015-08-06 Cadila Healtchare Limited Novel heterobicyclic compounds as kappa opioid agonists

Also Published As

Publication number Publication date
JP2020525548A (en) 2020-08-27
AU2018297214A1 (en) 2020-01-16
AU2018297214B2 (en) 2022-09-01
EP3649132A4 (en) 2021-04-07
CA3067398A1 (en) 2019-01-10
US20220288089A1 (en) 2022-09-15
IL271772A (en) 2020-02-27
EP3649132A1 (en) 2020-05-13
WO2019010014A1 (en) 2019-01-10
EP3649132B1 (en) 2023-12-27
US20210161912A1 (en) 2021-06-03
CN116440140A (en) 2023-07-18
CN111278831A (en) 2020-06-12
KR20200026962A (en) 2020-03-11
US11185551B2 (en) 2021-11-30
JP7233741B2 (en) 2023-03-07

Similar Documents

Publication Publication Date Title
EP3252525C0 (en) Display device and method for manufacturing the same
IL264931B (en) Therapeutic combinations comprising a raf inhibitor and a erk inhibitor
TWI561080B (en) Electronic device and method for manufacturing the same
TWI562766B (en) Non-invasive evaluation device for liver fibrosis and a method thereof
HUE061322T2 (en) Storage device and block storage method based on the storage device
TWI561154B (en) Charge cabinet and storage device thereof
HK1212864A1 (en) Hard panned coating and confection comprising the same
PL3306613T3 (en) Memory device and assembling method thereof
GB201613347D0 (en) Electronic device and dynamo random access memory thereof
EP3814065C0 (en) Storage device
HK1255048A1 (en) A geocell and the manufacturing method thereof
IL279276A (en) Erk inhibitor and use thereof
EP3817895C0 (en) Storage device
SG10201907261SA (en) Storage device
PT3479043T (en) The device for manufacturing and storing ice
IL271772A (en) A peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response
GB2562080B (en) A fungicidal composition and the use thereof
SG11201703976YA (en) Measuring device and method for measuring a hole in the ground
PL3589916T3 (en) Device and method for determining the length of a line
GB2553016B (en) Storage device and storage element
HU4987U (en) Enhanced secure solid state storage device
IL283106A (en) Erk inhibitors and uses thereof
GB2580964B (en) Storage Device
SG11202004931PA (en) Storage device
IL262317A (en) Intravascular access device displacement alerting apparatus and method